Josh Smith, MS, Chief Scientist and CEO of Premium CBD Labs, meet with COLA’s Board of Directors

On June 18, 2021, Josh Smith, MS, Chief Scientist and CEO of Premium CBD Labs, met with COLA’s Board of Directors to share his thoughts on the state of the cannabis industry, the challenges for the testing industry and the role of ISO 17025 as a foundation for technical competency and quality management. Josh is a well-known, well-respected technical and business thought leader within the industry with 15+ years of experience in pharmaceutical R&D and highly regulated clinical fields.  As a physician-directed organization, we were all eager for the discussions!  Special thanks to Josh for spending valuable time with our Board of Directors*.  We share your passion to bring clinical standards and best practices to the cannabis industry!